Member Log-in Follow us Twitter Logo
DNA Helix

Cofund on Biotechnologies

Innovation for Europe – life science meets market application

ERA CoBioTech Strategic Agenda – a vision for biotechnology in Europe

In a joint effort between the ERA CoBioTech partners and the European scientific community, ERA CoBioTech has developed a vision for the future of biotechnology in Europe.

ERA CoBioTech was built on and learns from three previous ERA-NETs: ERA-IB (Towards an ERA in Industrial Biotechnology), ERASynBio (ERA-NET on Synthetic Biology) and ERASysAPP (ERA-Net for Systems Biology Applications). With this  strategic agenda we build on the foundations established through these earlier programmes and provide continuity for the biotechnology sector. Harnessing the strength and innovative capacity of systems and synthetic biology tools to address industrial biotechnology challenges is a key mission for ERA CoBioTech, in order to drive industrial translation and innovation in Europe.

During the development of this document, three key themes were identified:

Theme 1: Research and technology to address sustainability in Europe and beyond

Theme 2: Streamlined and purpose orientated funding across Europe

Theme 3: Engaging the scientific community and beyond

The strategic agenda contains targeted recommendations on topics within each of these themes, which will support the entirebiotechnology community in their endeavours to increase Research, Development and Innovation (R, D&I) capability and capacity in this field.

This agenda is aligned with the soon to be released Agenda for Responsible Research and Innovation (RRI) in ERA CoBioTech which will outline how RRI can be embedded into biotechnology research on programme and project level, making it accessible for more groups of society.